vs

Side-by-side financial comparison of DoubleVerify Holdings, Inc. (DV) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.

iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $205.6M, roughly 1.0× DoubleVerify Holdings, Inc.). DoubleVerify Holdings, Inc. runs the higher net margin — 14.3% vs 2.7%, a 11.6% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 7.9%). DoubleVerify Holdings, Inc. produced more free cash flow last quarter ($62.1M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 20.8%).

Double Vision is a Malaysian production studio. Established in 1985, it has production hubs in Malaysia and Indonesia. Double Vision produces over 1,400 hours of television programming per year in various languages and genres for the regional market. It also houses international entertainment TV network, Channel [V], in its studios.

iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.

DV vs IRTC — Head-to-Head

Bigger by revenue
IRTC
IRTC
1.0× larger
IRTC
$208.9M
$205.6M
DV
Growing faster (revenue YoY)
IRTC
IRTC
+19.3% gap
IRTC
27.1%
7.9%
DV
Higher net margin
DV
DV
11.6% more per $
DV
14.3%
2.7%
IRTC
More free cash flow
DV
DV
$47.7M more FCF
DV
$62.1M
$14.5M
IRTC
Faster 2-yr revenue CAGR
IRTC
IRTC
Annualised
IRTC
25.8%
20.8%
DV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DV
DV
IRTC
IRTC
Revenue
$205.6M
$208.9M
Net Profit
$29.3M
$5.6M
Gross Margin
82.5%
70.9%
Operating Margin
18.4%
1.1%
Net Margin
14.3%
2.7%
Revenue YoY
7.9%
27.1%
Net Profit YoY
25.3%
518.5%
EPS (diluted)
$0.18
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DV
DV
IRTC
IRTC
Q4 25
$205.6M
$208.9M
Q3 25
$188.6M
$192.9M
Q2 25
$189.0M
$186.7M
Q1 25
$165.1M
$158.7M
Q4 24
$190.6M
$164.3M
Q3 24
$169.6M
$147.5M
Q2 24
$155.9M
$148.0M
Q1 24
$140.8M
$131.9M
Net Profit
DV
DV
IRTC
IRTC
Q4 25
$29.3M
$5.6M
Q3 25
$10.2M
$-5.2M
Q2 25
$8.8M
$-14.2M
Q1 25
$2.4M
$-30.7M
Q4 24
$23.4M
$-1.3M
Q3 24
$18.2M
$-46.2M
Q2 24
$7.5M
$-20.1M
Q1 24
$7.2M
$-45.7M
Gross Margin
DV
DV
IRTC
IRTC
Q4 25
82.5%
70.9%
Q3 25
82.3%
71.1%
Q2 25
82.5%
71.2%
Q1 25
81.2%
68.8%
Q4 24
82.0%
70.0%
Q3 24
82.6%
68.8%
Q2 24
83.3%
69.9%
Q1 24
81.1%
66.3%
Operating Margin
DV
DV
IRTC
IRTC
Q4 25
18.4%
1.1%
Q3 25
11.2%
-4.4%
Q2 25
7.2%
-10.0%
Q1 25
4.1%
-20.5%
Q4 24
20.3%
-2.5%
Q3 24
15.2%
-34.1%
Q2 24
7.1%
-15.5%
Q1 24
4.9%
-28.9%
Net Margin
DV
DV
IRTC
IRTC
Q4 25
14.3%
2.7%
Q3 25
5.4%
-2.7%
Q2 25
4.6%
-7.6%
Q1 25
1.4%
-19.3%
Q4 24
12.3%
-0.8%
Q3 24
10.7%
-31.3%
Q2 24
4.8%
-13.6%
Q1 24
5.1%
-34.6%
EPS (diluted)
DV
DV
IRTC
IRTC
Q4 25
$0.18
$0.18
Q3 25
$0.06
$-0.16
Q2 25
$0.05
$-0.44
Q1 25
$0.01
$-0.97
Q4 24
$0.14
$-0.03
Q3 24
$0.10
$-1.48
Q2 24
$0.04
$-0.65
Q1 24
$0.04
$-1.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DV
DV
IRTC
IRTC
Cash + ST InvestmentsLiquidity on hand
$259.0M
$583.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.1B
$152.7M
Total Assets
$1.4B
$1.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DV
DV
IRTC
IRTC
Q4 25
$259.0M
$583.8M
Q3 25
$200.7M
$565.2M
Q2 25
$216.8M
$545.5M
Q1 25
$174.3M
$520.6M
Q4 24
$310.6M
$535.6M
Q3 24
$362.6M
$522.0M
Q2 24
$338.8M
$561.5M
Q1 24
$334.3M
$569.1M
Stockholders' Equity
DV
DV
IRTC
IRTC
Q4 25
$1.1B
$152.7M
Q3 25
$1.1B
$121.9M
Q2 25
$1.1B
$103.7M
Q1 25
$1.0B
$86.7M
Q4 24
$1.1B
$90.9M
Q3 24
$1.1B
$71.8M
Q2 24
$1.1B
$99.2M
Q1 24
$1.1B
$90.3M
Total Assets
DV
DV
IRTC
IRTC
Q4 25
$1.4B
$1.0B
Q3 25
$1.3B
$995.2M
Q2 25
$1.3B
$964.0M
Q1 25
$1.2B
$926.1M
Q4 24
$1.3B
$931.4M
Q3 24
$1.3B
$909.7M
Q2 24
$1.3B
$919.2M
Q1 24
$1.3B
$909.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DV
DV
IRTC
IRTC
Operating Cash FlowLast quarter
$72.7M
$26.2M
Free Cash FlowOCF − Capex
$62.1M
$14.5M
FCF MarginFCF / Revenue
30.2%
6.9%
Capex IntensityCapex / Revenue
5.1%
5.6%
Cash ConversionOCF / Net Profit
2.48×
4.70×
TTM Free Cash FlowTrailing 4 quarters
$172.7M
$34.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DV
DV
IRTC
IRTC
Q4 25
$72.7M
$26.2M
Q3 25
$51.2M
$34.9M
Q2 25
$49.6M
$27.7M
Q1 25
$37.7M
$-7.9M
Q4 24
$37.4M
$19.2M
Q3 24
$54.6M
$24.3M
Q2 24
$35.9M
$11.8M
Q1 24
$31.8M
$-52.0M
Free Cash Flow
DV
DV
IRTC
IRTC
Q4 25
$62.1M
$14.5M
Q3 25
$39.0M
$20.1M
Q2 25
$40.1M
$17.3M
Q1 25
$31.4M
$-17.3M
Q4 24
$30.0M
$12.4M
Q3 24
$48.4M
$15.5M
Q2 24
$28.7M
$3.4M
Q1 24
$25.4M
$-61.8M
FCF Margin
DV
DV
IRTC
IRTC
Q4 25
30.2%
6.9%
Q3 25
20.7%
10.4%
Q2 25
21.2%
9.3%
Q1 25
19.0%
-10.9%
Q4 24
15.8%
7.5%
Q3 24
28.5%
10.5%
Q2 24
18.4%
2.3%
Q1 24
18.0%
-46.8%
Capex Intensity
DV
DV
IRTC
IRTC
Q4 25
5.1%
5.6%
Q3 25
6.4%
7.7%
Q2 25
5.0%
5.6%
Q1 25
3.8%
5.9%
Q4 24
3.9%
4.2%
Q3 24
3.7%
6.0%
Q2 24
4.6%
5.7%
Q1 24
4.5%
7.4%
Cash Conversion
DV
DV
IRTC
IRTC
Q4 25
2.48×
4.70×
Q3 25
5.02×
Q2 25
5.66×
Q1 25
15.95×
Q4 24
1.60×
Q3 24
3.00×
Q2 24
4.80×
Q1 24
4.44×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DV
DV

Activation$116.5M57%
Measurement$69.6M34%
Supply Side$19.5M9%

IRTC
IRTC

Commercial Payors$111.7M53%
Centers For Medicare And Medicaid$49.2M24%
Healthcare Institutions$34.3M16%
Non Contracted Third Party Payors$13.7M7%

Related Comparisons